Logo image of GUTS

FRACTYL HEALTH INC (GUTS) Stock Analyst Ratings

USA - NASDAQ:GUTS - US35168W1036 - Common Stock

1.25 USD
-0.03 (-2.34%)
Last: 10/29/2025, 8:00:01 PM
1.25 USD
0 (0%)
Pre-Market: 10/30/2025, 8:47:06 AM
Buy % Consensus

85

ChartMill assigns a Buy % Consensus number of 85% to GUTS. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 6.65. This target is 432.03% above the current price.
GUTS was analyzed by 11 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about GUTS.
In the previous month the buy percentage consensus was at a similar level.
GUTS was analyzed by 11 analysts, which is quite many. So the average rating should be quite meaningful.
GUTS Historical Analyst RatingsGUTS Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Price Target & Forecast

Price Low Median Mean High 1.253.646.126.6510.50 - 190.88% 389.60% 432.03% 740.00%
GUTS Current Analyst RatingGUTS Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4 5
Up and Down Grades
Date Firm Action Rating
2025-09-26 HC Wainwright & Co. Maintains Buy -> Buy
2025-09-15 HC Wainwright & Co. Initiate Buy
2025-08-28 Ladenburg Thalmann Initiate Buy
2025-08-14 Canaccord Genuity Maintains Buy -> Buy
2025-04-15 Canaccord Genuity Initiate Buy
2025-02-03 Morgan Stanley Maintains Overweight -> Overweight
2024-02-28 Evercore ISI Group Initiate Outperform
2024-02-27 Morgan Stanley Initiate Overweight

FRACTYL HEALTH INC / GUTS FAQ

What is the price target for GUTS stock?

11 analysts have analysed GUTS and the average price target is 6.65 USD. This implies a price increase of 432.03% is expected in the next year compared to the current price of 1.25.


How do analysts rate FRACTYL HEALTH INC (GUTS)?

The consensus rating for FRACTYL HEALTH INC (GUTS) is 85.4545 / 100 . This indicates that analysts generally have a positive outlook on the stock.